Patient Characteristics and Real-World Treatment Patterns Among Early Users of PCSK9 Inhibitors

ConclusionsPhysicians surveyed appeared to prescribe PCSK9i medications appropriately. PCSK9i-treated patients had higher rates of cardiovascular comorbidities and physician-determined statin intolerance, had higher LDL-C levels, and received more lines of therapy than non-PCSK9i patients.

http://link.springer.com/10.1007/s40256-017-0246-z

Source: American Journal of Cardiovascular Drugs - August 28, 2017 Category: Cardiology Source Type: research